Literature DB >> 24632381

Nrf2 expression and activity in human T lymphocytes: stimulation by T cell receptor activation and priming by inorganic arsenic and tert-butylhydroquinone.

Claudie Morzadec1, Mélinda Macoch1, Lydie Sparfel1, Saadia Kerdine-Römer2, Olivier Fardel3, Laurent Vernhet4.   

Abstract

The transcription factor nuclear factor-erythroid 2-related-2 (Nrf2) controls cellular redox homeostasis and displays immunomodulatory properties. Nrf2 alters cytokine expression in murine T cells, but its effects in human T lymphocytes are unknown. This study investigated the expression and activity of Nrf2 in human activated CD4(+) T helper lymphocytes (Th cells) that mediate the adaptive immune response. Th cells were isolated from peripheral blood mononuclear cells and activated with antibodies against CD3 and CD28, mimicking physiologic Th cell stimulation by dendritic cells. Nrf2 is hardly detectable in unstimulated Th cells. Activation of Th cells rapidly and strongly increases the levels of Nrf2 protein by increasing NRF2 gene transcription. Th cell activation also enhances mRNA and protein levels of Nrf2 target genes encoding antioxidant enzymes. Blocking Nrf2 expression using chemical inhibitors or siRNAs prevents these gene inductions. Pretreatment with inorganic arsenic, a Nrf2 inducer that does not alter NRF2 gene expression, increases protein level and transcriptional activity of Nrf2 induced by Th cell stimulation. Inorganic arsenic enhances nuclear translocation of Nrf2, its interaction with the coactivator protein p300, and its DNA binding activity. Inhibition of Nrf2 expression abrogates the effects of inorganic arsenic on mRNA levels of antioxidant genes, but does not alter the expression of IL-2, TNF-α, interferon-γ, or IL-17 in Th cells activated in the absence or presence of the metalloid. In conclusion, this study demonstrates for the first time that stimulation of human Th cells increases transcription of the NRF2 gene and activity of the Nrf2 protein. However, modulation of Nrf2 levels does not modify the secretion of inflammatory cytokines from these T lymphocytes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antioxidant genes; Arsenic; Cytokines; Free radicals; Nrf2; T lymphocytes

Mesh:

Substances:

Year:  2014        PMID: 24632381     DOI: 10.1016/j.freeradbiomed.2014.03.006

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  24 in total

1.  Protection of Nrf2 against arsenite-induced oxidative damage is regulated by the cyclic guanosine monophosphate-protein kinase G signaling pathway.

Authors:  Chengzhi Chen; Xuejun Jiang; Shiyan Gu; Yanhao Lai; Yuan Liu; Zunzhen Zhang
Journal:  Environ Toxicol       Date:  2016-10-24       Impact factor: 4.119

Review 2.  Old dog, new trick: Trivalent arsenic as an immunomodulatory drug.

Authors:  Yishan Ye; Béatrice Gaugler; Mohamad Mohty; Florent Malard
Journal:  Br J Pharmacol       Date:  2020-03-12       Impact factor: 8.739

3.  Nrf2-Dependent and -Independent Effects of tert-Butylhydroquinone, CDDO-Im, and H2O2 in Human Jurkat T Cells as Determined by CRISPR/Cas9 Gene Editing.

Authors:  Joseph W Zagorski; Tyler P Maser; Karen T Liby; Cheryl E Rockwell
Journal:  J Pharmacol Exp Ther       Date:  2017-03-09       Impact factor: 4.030

Review 4.  Redox regulation of immunometabolism.

Authors:  Jonathan Muri; Manfred Kopf
Journal:  Nat Rev Immunol       Date:  2020-12-18       Impact factor: 53.106

5.  Nrf2-dependent and -independent effects of tBHQ in activated murine B cells.

Authors:  Jenna K Bursley; Cheryl E Rockwell
Journal:  Food Chem Toxicol       Date:  2020-07-20       Impact factor: 6.023

6.  KEAP1 Editing Using CRISPR/Cas9 for Therapeutic NRF2 Activation in Primary Human T Lymphocytes.

Authors:  Sanjeev Noel; Sul A Lee; Mohanraj Sadasivam; Abdel R A Hamad; Hamid Rabb
Journal:  J Immunol       Date:  2018-01-19       Impact factor: 5.422

7.  The Nrf2 activator tBHQ inhibits T cell activation of primary human CD4 T cells.

Authors:  Alexandra E Turley; Joseph W Zagorski; Cheryl E Rockwell
Journal:  Cytokine       Date:  2014-12-05       Impact factor: 3.861

8.  Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in mice.

Authors:  Jennifer J Tsai; Enrico Velardi; Yusuke Shono; Kimon V Argyropoulos; Amanda M Holland; Odette M Smith; Nury L Yim; Uttam K Rao; Fabiana M Kreines; Sophie R Lieberman; Lauren F Young; Amina Lazrak; Salma Youssef; Ya-Yuan Fu; Chen Liu; Cecilia Lezcano; George F Murphy; Il-Kang Na; Robert R Jenq; Alan M Hanash; Jarrod A Dudakov; Marcel R M van den Brink
Journal:  Blood       Date:  2018-10-31       Impact factor: 22.113

9.  Differential expression of lncRNAs during the HIV replication cycle: an underestimated layer in the HIV-host interplay.

Authors:  Wim Trypsteen; Pejman Mohammadi; Clarissa Van Hecke; Pieter Mestdagh; Steve Lefever; Yvan Saeys; Pieter De Bleser; Jo Vandesompele; Angela Ciuffi; Linos Vandekerckhove; Ward De Spiegelaere
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

10.  Protective role of nuclear factor erythroid 2-related factor 2 in the hemorrhagic shock-induced inflammatory response.

Authors:  Haige Zhao; Sijing Hao; Hongfei Xu; Liang Ma; Zheng Zhang; Yiming Ni; Luyang Yu
Journal:  Int J Mol Med       Date:  2016-02-25       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.